CD34 and HIV-1 infection: HIV-1 peptides containing 36 or 46 amino acids from HR2 have been shown to inhibit HIV-1 infection in primary T cells when conjugated to membrane-associated scaffold proteins derived from the nerve growth factor receptor or CD34 [26, 27, 30, 33].